No Data
Xi'an Global Printing (002799.SZ): Currently, the company's revenue from overseas business accounts for a relatively small proportion.
Guangzhou Stock Exchange reported on January 17 that Xi'an Global Printing (002799.SZ) stated on an investor interaction platform that the company, as a professional provider of pharmaceutical packaging, is mainly engaged in the research and development, production, and sales of pharmaceutical packaging products, while also offering integrated packaging solutions for customers including project planning, graphic design, structural design, warehouse management, and logistics distribution. Currently, the overseas business revenue accounts for a small proportion, and the company will continue to pay attention to relevant industry and market dynamics, and based on the actual development of the company, will orderly promote overseas pharmaceutical packaging business under the premise of ensuring that risks are controllable.
Xi'an Global Printing (002799.SZ): Focus on the research and development, production, and services of high-end exquisite packaging and related packaging materials for paper products such as Cosmetic, medical instruments, health products, and fast-moving c
On December 18, Gelonghui reported that Xi'an Global Printing (002799.SZ) stated on the investor interactive platform that as a professional pharmaceutical packaging supplier, the company mainly engages in the research and development, production, and sales of pharmaceutical packaging products, and provides clients with integrated packaging solutions including program planning, graphic design, structural design, warehousing management, and Logistics distribution. At the same time, the company focuses on the research and development, production, and services of high-end exquisite paper packaging and related packaging materials for aesthetic cosmetics, medical instruments, health products, fast-moving consumer goods, and other categories.
Xi'an Global Printing (002799.SZ): Has maintained a good cooperative relationship with Eli Lilly and Co and Novo-Nordisk A/S.
Gelonghui reported on December 12 that Xi'an Global Printing (002799.SZ) stated on the investor interaction platform that the company has maintained a good cooperative relationship with Eli Lilly and Co, Novo-Nordisk A/S, and other enterprises. In the future, the company will continue to strengthen market development efforts and expand its customer base.
xi'an global printing (002799.SZ): Currently not involved in the field of computing power.
Gelonghui reported on November 27 that xi'an global printing (002799.SZ) stated on the investor interaction platform that the company is currently not involved in the computing power field.
Xi'an Global Printing (002799.SZ): No business cooperation with TikTok (overseas version of Douyin) at this time.
Gelonghui on November 26th, xi'an global printing (002799.SZ) stated on the investor interaction platform that its subsidiary Linkai Technology is a local life service provider for Douyin, with a relatively small business share in its subsidiary Linkai Technology. Investors should pay attention to investment risks. The company currently has no business cooperation with TikTok (Douyin's overseas version).
Global Printing: Report for the third quarter of 2024